Browning, M.J. and Bodmer, W.F. (1992) MHC antigens and cancer Implications for T-cell surveillance. Current Opinion in Immunology, 4, 613-618.doi10.1016/0952-7915(92)90036-E - References

Journals by Subject

Publish with us

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Article citationsMore>>

Browning, M.J. and Bodmer, W.F. (1992) MHC antigens and cancer: Implications for T-cell surveillance. Current Opinion in Immunology, 4, 613-618. doi:10.1016/0952-7915(92)90036-E

has been cited by the following article:

TITLE: New era in cancer immunotherapy: Twenty years to the discovery of monoclonal antibodies harnessing the immune system to eradicate tumors

AUTHORS: Britta Hardy, Annat Raiter

KEYWORDS: Cancer Immunotherapy; Monoclonal Antibodies; Anergy; T Cell Receptors

JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.4 No.4A, April 29, 2013

ABSTRACT: The better understanding of the mechanism in which the immune system responds to the developing cancer provided the outcome in a new era in cancer immunotherapy. The tumor suppressive effect on the immune system is caused by negative T cell receptor signaling that abrogate immunity against the cancer cells. Novel monoclonal antibodies that target co-inhibitory receptors on T cells block the tumor induced inhibition of the immune system and enable the immune system to eradicate the tumors. The development of such antibodies started twenty years ago by the preparation of a monoclonal antibody termed BAT. A single administration of the antibody to tumor bearing mice resulted in striking anti tumor activity that was mediated by the lymphocytes. These studies provided a basis for the new era of cancer immunotherapy. The present review summarizes twenty years to the discovery of monoclonal antibodies harnessing the immune system to eradicate tumors.

Open Access

Articles

Primary CNS T-Cell Lymphoma: A Case Report on a Solitary Cerebellar Lesion and Review of Current Relevant Literature

Aden McLaughlin, Sharon Gabizon

Open Journal of Modern Neurosurgery Vol.3 No.2, April 10, 2013

DOI: 10.4236/ojmn.2013.32004
Open Access

Articles

Relationship between Circulating Plasma Galectin-3 Levels and T-Cell Activation during Cervical Cancer Chemotherapy

Folly M. Gaba, Maïmouna Diop, Doudou G. M. Niang, Sidy Ka, Doudou Diouf, Moussa Ndour, Comlan J. G. Montcho, Moustapha Mbow, Babacar Faye, Rokhaya N. Diallo, Maguette S. Niang, Ahmadou Dem, Babacar Mbengue, Alioune Dieye

Open Journal of Immunology Vol.13 No.1, March 15, 2023

DOI: 10.4236/oji.2023.131002
Open Access

Articles

Sensitivity of a Rapid Mix Test with Combined Synthetic Antigens Derived from Mycobacterium Leprae PGL-1 for Diagnosis and Surveillance of Leprosy

Maria do Perpétuo Socorro Amador Silvestre, Maxwell Furtado de Lima, Antônio G. P. Pereira, Aline Rodrigues Bernardo, Rafaela Lopes Diniz, Pedro Paulo Ferreira Ribeiro, Edimílson Domingos da Silva, Luana Nepomuceno Gondim Costa Lima

Open Journal of Immunology Vol.10 No.1, January 31, 2020

DOI: 10.4236/oji.2020.101001
Open Access

Articles

Epidemiology of Mpox Outbreaks and Implications for Surveillance in Imo State, Nigeria

Adeniyi A. Adeniran, Ebubechi C. Eronini, Olugbenga Asaolu, Simisola Adedeji, Adaeze Joy Ugwu, Marcus Oludare, Faith Ehiaghe Ugba, Aibinuomo Ayomide Oluwaseyi, Tella Adedamola, Dania Oluyinka, Olayiwola Olanike Suliat, Oladele Tinuola, Daniel Musa Haruna, Adebayo O. Amao, John O. Ibitoye, Oluwagbemiga Obembe, Christopher Obanubi, Abdulmalik Abubakar

Advances in Infectious Diseases Vol.14 No.1, March 15, 2024

DOI: 10.4236/aid.2024.141015
Open Access

Articles

Low Dose of IL-12 Stimulates T Cell Response in Cultures of PBMCs Derived from Non Small Cell Lung Cancer Patients

Lucia D’Amico, Enrico Ruffini, Riccardo Ferracini, Ilaria Roato

Journal of Cancer Therapy Vol.3 No.4A, September 12, 2012

DOI: 10.4236/jct.2012.324044

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals by Subject

Publish with us

Article citationsMore>>

Home

About SCIRP

Service

Policies